Ramírez AI, Roy GI

Language: Spanish
References: 25
Page: 123-128
PDF size: 167.70 Kb.

ABSTRACT

Objective: to determine the impact on quality of life in the use of inhalers in patients with chronic obstructive pulmonary disease (COPD). Methods: analytical and cross-sectional study. Patients using inhalers, aged 40 to 85 years, diagnosed with COPD, attending the Family Medicine Unit (FMU) no. 28 of the Mexican Institute of Social Security Institute (IMSS) were included. The evaluation of the technique of using inhalers was carried out through a checklist, quality of life was measured using the COPD Assessment Test (CAT), adherence to treatment was carried out using the Morinsky-Green test, staging the degree of severity of copd was implemented on the Medical Research Council (MRC) dyspnoea scale; the progression of the disease, exacerbations, hospitalizations over the past year, as well as the use of oxygen therapy were also analyzed. Results: a total of 330 participants were included, of whom 220 were women (60.4%), with an average age of 74 years, interquartile range (IR) 66.83, with adherence to pharmacological treatment in 313 patients (94.8%), of whom 129 showed an adequate technique of use of inhalers (39.1%). The highest number of exacerbations and hospitalizations were found in patients with high and very high impact on quality of life. Risk factors found impacting the quality of life of these patients were: inadequate technique of use of inhalers, which showed an or of 5.35 (CI 95% 1.92-14.86), as well as age and body mass index (BMI). Conclusions: the inadequate technique of use, older age and bmi ‹23 are variables that deteriorate the quality of life of copd patients. The correct use of inhalers should be an indispensable part of treating copd patients.

REFERENCES

1. Buist A, McBurnie M, Vollmer W, Gillespie S, Burney P, Mannino DM, et al. International variation in the prevalence of COPD (the BOLD Study): a populationbased prevalence study. The Lancet. 2017;370(9589):741-50.

2. Rycroft C, Heyes A, Lanza L, Becker K. Epidemiology of chronic obstructive pulmonary disease: a literature review. International Journal of Chronic Obstructive Pulmonary Disease. 2012;7:457-494.

3. López Giraldo A, Rodriguez Roisin R, Agustí García Navarro A. Enfermedad pulmonar obstructiva crónica. Actualización 2014. Medicina Balear. 2013;29(1):43-48.

4. Welte T, Miravitlles M, Hernandez P, Eriksson G, Peterson S, Polanowski T, et al. Efficacy and tolerability of budesonide/formoterol added to tiotropium in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2009;180(8):741-50.

5. Fernández López L, Fernández Fidalgo F, Cieza A. Los conceptos de calidad de vida, salud y bienestar analizados desde la perspectiva de la Clasificación Internacional del Funcionamiento (CIF). Revista española de salud pública. 2010;84:169-184.

6. Dekhuijzen PR, Bjermer L, Lavorini F, Ninane V, Molimard M, Haughney J. Guidance on handheld inhalers in Asthma and COPD guidelines. Respiratory Medicine. 2014;108(5):694-700.

7. Casanova C, García I, Torres JP. La disnea en la EPOC. Arch Bronconeumol. 2015;41(3):24–32.

8. Brandl M, Böhmer M, Brandstetter S, Finger T, Fischer W, Pfeifer M, et al. Factors associated with generic health-related quality of life (HRQOL) in patients with chronic obstructive pulmonary disease (COPD): a cross-sectional study. Journal of thoracic disease. 2018;10(2):766-775.

9. Wacker E, Hunger M, Karrasch S, Heinrich J, Peters A, Schulz H, et al. Health-related quality of life and chronic obstructive pulmonary disease in early stages-longitudinal results from the populationbased cohort in a working age population. BMC pulmonary medicine. 2014;14(1):134.

10. Pedrozo Pupo JC, Campo Arias A. Desempeño clinimétrico de la escala de evaluación de la EPOC (CAT). Neumología y Cirugía de tórax. 2017;76(3):248-252.

11. Rodríguez Chamorro MA, García Jiménez E, Amariles Muñoz P, Rodríguez Chamorro A, Faus Dáder MJ. Revisión de test de medición del cumplimiento terapéutico utilizado en la práctica clínica. Atención Primaria. 2008;40(8):423-7.

12. Peduzzi P, Concato J, Kemper E, Holford TR, Feinstein AR. A simulation study of the number of events per variable in logistic regression analysis. Journal of Clinical Epidemiology. 1996;49(12):1373-9.

13. Austin PC, Steyerberg EW. The number of subjects per variable required in linear regression analyses. Journal of Clinical Epidemiology. 2015;68(6):627-36.

14. Global Initiative for Chronic Obstructive Lung Disease. Global Obstructive Lung Disease. 2019:63-82.

15. Golpe Gómez R, Mateos Colino A, Soto Franco I. Técnica inadecuada en el empleo de inhaladores en pacientes atendidos en una consulta de neumología. Anales de Medicina Interna. 2001;18(2):25-29.

16. Horvat N, Locatelli I, Kos M, Janežič A. Medication adherence and health-related quality of life among patients with chronic obstructive pulmonary disease. Acta Pharmaceutica. 2018;68(1):117-125.

17. Usmani S, Lavorini F, Marshall J, Heron L, Farrington E, et al. Critical inhaler errors in asthma and COPD: a systematic review of impact on health outcomes. Respiratory research. 2018;19(1):10.

18. Shavro SA, Ezhilarasu P, Augustine J, Bechtel JJ, Christopher D. Correlation of health-related quality of life with other disease severity indices in Indian chronic obstructive pulmonary disease patients. International Journal of Chronic Obstructive Pulmonary Disease. 2012;7:291-296.

19. Durán Montes LA, Cisneros Sandoval FJ, Gutiérrez Román EA. Calidad de vida en enfermedad pulmonar obstructiva crónica: experiencia de un hospital del occidente, México. Revista Médica del Instituto Mexicano Seguro Social. 2015;53(3):380-5.

20. Debigaré R, Marquis K, Côté H, Tremblay R, Michaud A, LeBlanc P, et al. Catabolic/anabolic balance and muscle wasting in patients with COPD. Chest. 2003;124(1):83-9.

21. Alcolea Batres S, Villamor León J, Álvarez-Sala R. EPOC y estado nutricional. Archivos Bronconeumología. 2007;43(5):283-8.

22. Mete B, Pehlivan E, Gulbas G, Günen H. Prevalence of malnutrition in COPD and its relationship with the parameters related to disease severity. International Journal of Chronic Obstructive Pulmonary Disease. 2018;13:3307-3312.

23. Martinez CH, Diaz AA, Parulekar AD, Rennard SI, Kanner RE, Hansel NN, et al. Age-Related Differences in Health-Related Quality of Life In COPD: an analysis of the COPDGene and SPIROMICS cohorts. Chest. 2016;149(4):927-935.

24. Rawal G, Yadav S. Nutrition in chronic obstructive pulmonary disease: A review. Journal of Translational Internal Medicine. 2015;3(4):151-154.

25. Collado Mateo D, Adsuar JC, Olivares PR, García Gordillo MA. Calidad de vida relacionada con la salud en personas chilenas con enfermedad pulmonar obstructiva crónica. Revista Médica de Chile. 2017:145(2):147-155.